This topic contains a solution. Click here to go to the answer

Author Question: Those with a hypersthenic build have a massive, truncated build with a short, broad, and deep ... (Read 79 times)

nramada

  • Hero Member
  • *****
  • Posts: 580
Those with a hypersthenic build have a massive, truncated build with a short, broad, and deep thorax.
 
 Indicate whether the statement is true or false

Question 2

Those with a sthenic build have a massive, truncated build with a short, broad, and deep thorax.
 
 Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Sweetkitty24130

  • Sr. Member
  • ****
  • Posts: 291
Answer to Question 1

True

Answer to Question 2

False




nramada

  • Member
  • Posts: 580
Reply 2 on: Jul 17, 2018
Thanks for the timely response, appreciate it


bbburns21

  • Member
  • Posts: 336
Reply 3 on: Yesterday
Excellent

 

Did you know?

Long-term mental and physical effects from substance abuse include: paranoia, psychosis, immune deficiencies, and organ damage.

Did you know?

Elderly adults are at greatest risk of stroke and myocardial infarction and have the most to gain from prophylaxis. Patients ages 60 to 80 years with blood pressures above 160/90 mm Hg should benefit from antihypertensive treatment.

Did you know?

Signs of depression include feeling sad most of the time for 2 weeks or longer; loss of interest in things normally enjoyed; lack of energy; sleep and appetite disturbances; weight changes; feelings of hopelessness, helplessness, or worthlessness; an inability to make decisions; and thoughts of death and suicide.

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library